WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death

GENEVA — The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with COVID-19 after they failed to reduce mortality. Read More

from Canoe https://ift.tt/3gqZ3fF